Briacell Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.18

+0.01 (+0.24%)

As of Feb 8, 2:21 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +492.1% upside

Low Target $18.09

Average Target $24.75

High Target $34.06

Current Price $4.18

Current
$4.18

Target
$24.75

$18.09 $24.75 avg $34.06

Scenario Analysis

Bear Case

$18.09

332.8%

Low target

Base Case

$24.75

+492.1%

Avg target

Bull Case

$34.06

+714.8%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$23.94

-82.5% from high

52-Week Low

$17.50

+-76.1% from low

Target vs 52W High

$24.75

+3.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%